With the Supreme Court about to hear a landmark case on gene patents, Myriad Genetics, the company that owns the patents under scrutiny, is going on the offensive. I've written about this case before, when the patents were first thrown out by one court, and then restored by another. Now the Supremes will have the final say.
With the Supreme Court about to hear a landmark case on gene patents, Myriad Genetics, the company that owns the patents under scrutiny, is going on the offensive. I've written about this case before, when the patents were first thrown out by one court, and then restored by another. Now the Supremes will have the final say.
Share this Article
Recommended